Krebs Biochemicals and Industries Limited · KREBSBIO
Every Krebs Biochemicals and Industries Limited result whose ten-session window has closed, judged against the last read made before it. Open a result for the full account: the read, the sessions after, the reported figures, and every morning's read that led up to it. The company's own page →
25results judged
0read right
0read wrong
0flat / no call
25unread
28%beat the market
-1.5%avg vs market, 10d
3.5%avg move, T+1
How the reads on it fared
| Read | Judged | Right | Wrong | Flat | Hit rate | Avg vs mkt | |
|---|---|---|---|---|---|---|---|
| unread | 25 | 0 | 0 | 0 | — | -1.5% |
A company that is often read strong and often proves it is one the model understands; one that is read strong and keeps lagging is where the model is wrong about a name, and this table is where that shows first.
Reading the rows
- T+1
- the share's move on the first session after the result, from the close before it
- T+10
- the move over ten sessions, same base
- vs market
- T+10 less NIFTY 50's move over the same ten sessions — the number every read is judged on
- Run-up
- the share's move in the thirty sessions before the result
- Result
- reported profit growth against the company's own last four quarters: good, in line, bad
Each result
25 judged · newest first · open one| Result | Read | Outcome | T+1 | T+10 | vs market | Run-up | Result | Why | |
|---|---|---|---|---|---|---|---|---|---|
| 6 Aug Q1FY27 | — | unread | +5.0% | -1.7% | -0.1% | -18% | no figures |
|
› |
| 21 May Q4FY26 | — | unread | +10.2% | +15.9% | +17.2% | -9% | no figures |
|
› |
| 9 Feb Q3FY26 | — | unread | +1.2% | +2.3% | +4.0% | -20% | no figures |
|
› |
| 4 Nov Q2FY26 | — | unread | -1.3% | -3.3% | -5.6% | -12% | no figures |
|
› |
| 7 Aug Q1FY26 | — | unread | +0.3% | -3.0% | -4.5% | -12% | no figures |
|
› |
| 20 May Q4FY25 | — | unread | -3.1% | +2.8% | +3.1% | +6% | no figures |
|
› |
| 4 Feb Q3FY25 | — | unread | -4.8% | -16.5% | -13.1% | +2% | no figures |
|
› |
| 11 Nov Q2FY25 | — | unread | -3.2% | +42.3% | +41.8% | +7% | no figures |
|
› |
| 7 Aug Q1FY25 | — | unread | +0.1% | +1.2% | -2.3% | +21% | no figures |
|
› |
| 22 May Q4FY24 | — | unread | -4.1% | -7.2% | -7.6% | -3% | no figures |
|
› |
| 12 Feb Q3FY24 | — | unread | +0.1% | -1.8% | -4.5% | -6% | no figures |
|
› |
| 8 Nov Q2FY24 | — | unread | -5.7% | -7.8% | -9.6% | +27% | no figures |
|
› |
| 9 Aug Q1FY24 | — | unread | -2.5% | +2.7% | +4.6% | -2% | no figures |
|
› |
| 24 May Q4FY23 | — | unread | -7.1% | -2.9% | -5.3% | -23% | no figures |
|
› |
| 3 Feb Q3FY23 | — | unread | +0.5% | -9.4% | -9.3% | -14% | no figures |
|
› |
| 11 Nov Q2FY23 | — | unread | -2.2% | -4.9% | -6.1% | +2% | no figures |
|
› |
| 1 Aug Q1FY23 | — | unread | -6.8% | -5.3% | -8.8% | +19% | no figures |
|
› |
| 23 May Q4FY22 | — | unread | -8.1% | -8.1% | -9.4% | -30% | no figures |
|
› |
| 13 Feb Q3FY22 | — | unread | -5.3% | -2.5% | +0.9% | -26% | no figures |
|
› |
| 10 Nov Q2FY22 | — | unread | -2.9% | +0.6% | +3.4% | -7% | no figures |
|
› |
| 30 Jul Q1FY22 | — | unread | -6.7% | +21.8% | +16.7% | +7% | no figures |
|
› |
| 27 May Q4FY21 | — | unread | -1.9% | -0.6% | -3.6% | +24% | no figures |
|
› |
| 30 Jan Q3FY21 | — | unread | -1.0% | -7.9% | -20.2% | +10% | no figures |
|
› |
| 5 Nov Q2FY21 | — | unread | -2.7% | -3.8% | -9.9% | +4% | no figures |
|
› |
| 7 Aug Q1FY21 | — | unread | -0.7% | -7.3% | -9.5% | +21% | no figures |
|
› |